Category: Antibody Technologies
Antibody Technologies market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Next-Generation Antibodies
The 2025-2030 World Outlook for Next-Generation Antibodies This study covers the world outlook for next-generation antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Selective Inhibitor of Cytokine Production and Function Organ Transplant Immunosuppressants
The 2025-2030 World Outlook for Selective Inhibitor of Cytokine Production and Function Organ Transplant Immunosuppressants This study covers the world outlook for selective inhibitor of cytokine production and function organ transplant immunosuppressants across more than 190 countries. For each yea ... Read More
-
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics
The 2025-2030 World Outlook for Next Generation Antibody Therapeutics This study covers the world outlook for next generation antibody therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Mammalian Polyclonal IgG Antibodies
The 2025-2030 World Outlook for Mammalian Polyclonal IgG Antibodies This study covers the world outlook for mammalian polyclonal IgG antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs
The 2025-2030 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs This study covers the world outlook for bioengineered monoclonal antibodies protein drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Combination Antibody Therapies
The 2025-2030 World Outlook for Combination Antibody Therapies This study covers the world outlook for combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies This study covers the world outlook for biosimilar monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody (MAb)-Based Products
The 2025-2030 World Outlook for Monoclonal Antibody (MAb)-Based Products This study covers the world outlook for monoclonal antibody (MAb)-based products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Hyperimmune Globulins
The 2025-2030 World Outlook for Hyperimmune Globulins This study covers the world outlook for hyperimmune globulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Plasma Protein Therapeutics
The 2025-2030 World Outlook for Plasma Protein Therapeutics This study covers the world outlook for plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Immunoglobulin a (IgA)
The 2025-2030 World Outlook for Immunoglobulin a (IgA) This study covers the world outlook for immunoglobulin a (IgA) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2025-2030 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies This study covers the world outlook for chemotherapy and antibody combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Catalog Antibody Immunochemicals
The 2025-2030 World Outlook for Catalog Antibody Immunochemicals This study covers the world outlook for catalog antibody immunochemicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies (mAbs)
The 2025-2030 World Outlook for Monoclonal Antibodies (mAbs) This study covers the world outlook for monoclonal antibodies (mAbs) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies Protein Therapeutics
The 2025-2030 World Outlook for Monoclonal Antibodies Protein Therapeutics This study covers the world outlook for monoclonal antibodies protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for HER2 Antibodies
The 2025-2030 World Outlook for HER2 Antibodies This study covers the world outlook for HER2 antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics This study covers the world outlook for recombinant plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies Market in Breast Cancers
The 2025-2030 World Outlook for Monoclonal Antibodies Market in Breast Cancers This study covers the world outlook for monoclonal antibodies market in breast cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Recombinant Proteins for Life Sciences
The 2025-2030 World Outlook for Recombinant Proteins for Life Sciences This study covers the world outlook for recombinant proteins for life sciences across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Research Antibodies
The 2025-2030 World Outlook for Research Antibodies This study covers the world outlook for research antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
Research Assistance
